1. Home
  2. HLIT vs IMTX Comparison

HLIT vs IMTX Comparison

Compare HLIT & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmonic Inc.

HLIT

Harmonic Inc.

HOLD

Current Price

$11.78

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

IMTX

Immatics N.V.

HOLD

Current Price

$9.56

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLIT
IMTX
Founded
1988
N/A
Country
United States
Germany
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
HLIT
IMTX
Price
$11.78
$9.56
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$14.67
$19.00
AVG Volume (30 Days)
1.5M
565.6K
Earning Date
05-11-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
N/A
N/A
Revenue This Year
$42.73
N/A
Revenue Next Year
$18.36
$25.91
P/E Ratio
$235.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.47
$5.67
52 Week High
$17.68
$12.41

Technical Indicators

Market Signals
Indicator
HLIT
IMTX
Relative Strength Index (RSI) 42.45 51.25
Support Level $11.38 $9.37
Resistance Level $12.48 $10.55
Average True Range (ATR) 0.39 0.46
MACD -0.06 0.04
Stochastic Oscillator 5.83 69.13

Price Performance

Historical Comparison
HLIT
IMTX

About HLIT Harmonic Inc.

Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.

About IMTX Immatics N.V.

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Share on Social Networks: